VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
ZOZO, Inc. vs GSK plc
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
ZOZO, Inc.
3092 · Tokyo Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
GSK plc
GSK · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: ZOZO, Inc. leads (63 / 100 vs 62 / 100 for GSK plc).
- Segment focus: ZOZO, Inc. has 5 segments (71.3% in ZOZOTOWN Business); GSK plc has 3 segments (37.6% in Specialty Medicines).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Moderate vs Strong.
- Moat breadth: ZOZO, Inc. has 5 moat types across 3 domains; GSK plc has 4 across 3.
Primary market context
ZOZO, Inc.
ZOZOTOWN Business
Japan online fashion marketplace and resale (ZOZOTOWN)
Japan
Consumers (buyers) and fashion brands/retailers (sellers/tenants)
Marketplace operator + retailer (mix of consignment, inventory retail, and used sales)
71.3%
GSK plc
Specialty Medicines
Branded specialty pharmaceuticals (HIV, oncology, immunology/respiratory)
Global
Hospitals, specialist physicians, payers
Innovator & branded manufacturer
37.6%
Side-by-side metrics
Moat coverage
Shared moat types
ZOZO, Inc. strengths
GSK plc strengths
Segment mix
ZOZO, Inc. segments
Full profile >ZOZOTOWN Business
Oligopoly
LY Corporation Commerce
Competitive
BtoB business
Competitive
Advertising business (ZOZOAD / WEAR reach monetization)
Monopoly
Others (platform services, shipping/settlement fees, and options)
Monopoly
GSK plc segments
Full profile >Vaccines
Oligopoly
Specialty Medicines
Oligopoly
General Medicines
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.